2003-2004 Antiviral Review 22 November 2018 12:45 PM.

Slides:

Advertisements

Similar presentations

Treatment Recommendations of swine flu By Nesrien Mohammed Shalabi Ass. Prof of Thoracic Medicine 5/5/2009.

Advertisements

Think Health. Act Now!. CITY OF MILWAUKEE HEALTH DEPARTMENT. Content in this presentation may not be duplicated, copied, or reproduced.

Information source: Swine Flu What is Swine Influenza? Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza.

1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.

Avian Influenza – The Bird Flu

Antivirals Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant. It has.

80% Influenza A — H3N2 (some H1N1) 20 % influenza B (orthomyoxiviridae – seals and humans only) Deaths above epidemic threshold – 50% hospitalizations.

Influenza Sara Finestone April 8, The influenza virus causes 3-5 million cases of severe illness and up to 500,000 deaths annually.

Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.

1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.

Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 40 Antiviral Drugs.

Antiviral Drugs.

Antiviral Agents Scott M. Hammer, M.D.. Challenges to the Development of Effective Antiviral Agents Myriad number of agents Need knowledge of replication.

Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.

Antiviral Agents Upton D. Allen. Outline of Presentation Herpes group agents Anti-influenza agents Anti-hepatitis agents Anti-RSV Immune response modifiers.

Hugh B. Fackrell Filename: orthomyx.ppt

Emerging Viruses BY PLAN A. Topic Questions  Why are these new viruses more harmful compared to the previous form of the virus?  Why is it so difficult.

Influenza of 1918 Danielle Albin Dane van Loon Matthew Litch.

H1N1 (Swine Flu) By SierraLynn Johnson. Description of H1N1  H1N1 (Swine Flu) is a respiratory illness found in pigs or an infection cause by a virus.

Anti-Fungal Compounds Eukaryotic pathogens –Similar cell structure and function Many fungi are opportunistic –Fungal infections on the rise Most have detoxification.

Influenza A/H1N1 W. Rose H1N1 is a subtype of influenza type A Influenza types B and C also exist but less common, less infectious, and drift.

Influenza Today Joseph Mester, Ph.D. September 24, 2009.

Influenza Causative Agent Orthomyxovirus Influenza A virus

IV. Antihepatitis Agents: Like in AIDS, they are suppressive rather than curative. Among many hepatitis viruses, HBV and HCV are the most common cause.

Avian Influenza H5N1 Prepared by: Samia ALhabardi.

Antiviral Drugs. Mechanism of Action Picornaviruses eg, polioviruses, cold viruses Block attachment molecule on host cell or pathogen Attachment antagonists.

Antiviral Agents Scott M. Hammer, M.D.. Challenges to the Development of Effective Antiviral Agents Myriad number of agents Need knowledge of replication.

Antiviral Agents.

ANTIVIRAL AGENTS FOR THE PREVENTION AND TREATMENT ON INFLUENZA.

Review: Viruses Virus Genome Polarity Segments Morphology Enveloped Diseases Picorna RNA +ss 1 Icosahedral No Polio, Hepatitis A, Colds Toga RNA +ss 1 Icosahedral Yes Encephalitis,

Antiviral Agents, chapter 39 Different living organisms.

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 39 Antiviral Drugs.

It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.

RSV: RESPIRATORY SYNCYTIAL VIRUS Barbara Woodall.

Who Knew? The Flu and YOU! By: Christine Antler and Erin Boyle.

 Recognition  Attachment  Penetration  Uncoating  Early protein synthesis  Nucleic acid synthesis  Late protein synthesis  Assembly  Release.

Two different therapeutic approaches for treating: A.A DNA virus (e.g. Herpes) B.An RNA virus (e.g. Influenza)

Influenza. n Begins abruptly n 20% to 50% of population affected n Complications can develop n Enter thru mucous membranes of eyes, nose or mouth n Contagious.

Orthomyxoviridae Influenza Virus. Properties Spherical Virion ( polymorphic) Spherical Virion ( polymorphic) 100 nm Size 100 nm Size Segmented –SS-RNA.

Antiviral drugs.

Immunopharmacology 8 March :42 AM.

Antiviral Therapy. Table for antiviral Drug:Viruses: Chemical Type: Target: Acyclovir, VidarabineHerpesviruses (HSV) Nucleoside analogues Virus polymerase.

Antiviral agents Hamzeh Elayan

Antiviral Drugs Viruses are obligate intracellular parasites.

Oseltamivir Neuraminidase inhibitor

Orthomyxoviridae Is enveloped virus, helical nucleocapsid

VIRAL INFLUENZA.

THE INFECTIOUS PROCESS FOR A VIRUS Despite their simplicity relative to bacteria, viruses still possess various biochemical targets for potential attack.

SUMMARY + QUIZ + helpful videos

Antivirals Essential idea

SWINE FLU NEHA SRIVASTAVA M.PHARM (PHARMACOLOGY).

Antiviral chemotherapy

Antiviral Drugs.

Antiviral drugs Mr. OLORO JOSEPH..

PHARMACOTHERAPY III PHCY 510

Treatment of Infectious Diseases

Antiviral Drugs Viruses are obligate intracellular parasites.

Antiviral Drugs Chapter 45.

دانشگاه علوم پزشکی کرمانشاه حوزه معاونت امور بهداشتی آذرماه 1394

Antiviral Agents.

Battling the Flu: Latest Advances in the Influenza Treatment Arsenal

The Upper Respiratory System

Antiviral agents.

Development of Effective Vaccines against Pandemic Influenza

Investigate the Treatment of Infectious Diseases

Avian influenza ( Bird flu )

Antiviral chemotherapy

Tertiary structures of influenza virus proteins (matrix 2, neuraminidase, and RNA polymerase) and chemical formulas of influenza virus inhibitors. Tertiary.

Evidence-based management of bronchiolitis.

Presentation transcript:

2003-2004 Antiviral Review 22 November 2018 12:45 PM

Antiviral Antiparkinson Amantadine Antiviral Antiparkinson Treatment of Influenza A Inhibits replication at the stage of uncoating

Oseltamivir Antiviral Inhibits neuraminidase and decreases viral release Treatment of Influenza A & B

Monoclonal antibody against the surface of respiratory syncytial virus Palivizumab Antiviral Monoclonal antibody against the surface of respiratory syncytial virus

Primarily used as aerosol for respiratory syncytial virus Ribavirin Antiviral Primarily used as aerosol for respiratory syncytial virus

Rimantadine Antiviral Inhibits replication at the stage of uncoating Treatment of Influenza A

Zanamivir Antiviral Inhibits neuraminidase and decreases viral release Treatment of Influenza A & B